Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin Plus Biphasic Insulin Aspart vs Insulin NPH in Type 2 Diabetes
NCT00592969Phase 4Completed
- Sponsor
- Novo Nordisk
- Start
- Dec 2003
- Primary completion
- Nov 2004
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 4 trial of Insulin aspart + insulin aspart protamine in type 2 diabetes mellitus (T2DM), sponsored by Novo Nordisk. Started Dec 2003; status: completed.
02
Drugs
Insulin aspart + insulin aspart protamine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00592969.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00592969.